Inspira Technologies Oxy B.H.N. Ltd.

Equities

IINN

IL0011715781

Advanced Medical Equipment & Technology

Delayed Nasdaq 03:38:17 2024-04-19 pm EDT 5-day change 1st Jan Change
1.84 USD +1.66% Intraday chart for Inspira Technologies Oxy B.H.N. Ltd. -10.25% +73.58%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Inspira, Beilinson Hospital Collaborate on Organ Transplant Device Evaluation MT
Inspira?? and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth Causes Bloodstream Infections CI
Inspira? Technologies Oxy B.H.N. Ltd. Announces Program to Pioneer the Applicable Use of the INSPIRA? ART100 Device for an Artificial Womb CI
Inspira Technologies Oxy B.H.N. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Inspira Technologies OXY B.H.N. Ltd. Announces AMAR Regulatory Submission of the INSPIRA? ART100, to Enter the Southeast Asia and South American Markets CI
Inspira Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator CI
Inspira Technologies Oxy B.H.N. Ltd. Plans to Report the Primary Results for A Core Blood Oxygenation Technology Within Days CI
Inspira Technologies Oxy B.H.N. Ltd. Announces Approval from the U.S. Food & Drug Administration for its INSPIRA ART100 in the First Half of 2024 CI
Inspira Technologies OXY B.H.N. Ltd. Introduces High-End Platform for Bio-Mimicking Blood parameters for Development and Testing of Core Technologies CI
Sector Update: Health Care Stocks Gain Late Afternoon MT
Sector Update: Health Care Stocks Rise in Afternoon Trading MT
Sector Update: Health Care MT
Inspira Gets US Patent Approval for Orbiting Blood Oxygenation Delivery System; Shares Rise MT
Inspiratm Technologies OXY B.H.N. Ltd. Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System CI
Inspira? Technologies Collaborates with Shamir Medical Center CI
Inspira? Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 Inspira? Art Devices CI
Inspira Technologies Oxy B.H.N. Ltd. Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for A New Disposable Perfusion Market Opportunity CI
Inspira Technologies Oxy B.H.N. Ltd. Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA? ART100 Device CI
Inspira Technologies Closes $3.88 Million Offering MT
Sector Update: Health Care Stocks Stronger Late Afternoon MT
Sector Update: Health Care MT
Inspira Technologies Shares Rise After Promising Results for Blood Sensor; Raises $3.9 Million via Offering MT
Inspira Technologies OXY BHN Ltd. Announces 95% Accuracy Results for HYLA?? Blood Sensor, Planning FDA Submission for Clearance in 2024 CI
Inspira Technologies Oxy B.H.N. Ltd. Announces Appointment of Dan Gorfil to its Medical Advisory Board CI
Inspira Collaborates with Ennocure for Development of Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients CI
Chart Inspira Technologies Oxy B.H.N. Ltd.
More charts
Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.81 USD
Average target price
13 USD
Spread / Average Target
+618.27%
Consensus
  1. Stock Market
  2. Equities
  3. IINN Stock
  4. News Inspira Technologies Oxy B.H.N. Ltd.
  5. Inspira Technologies Lists ART, ECLS Systems Component on FDA's Class I Exempt List